Hansoh Pharmaceutical Group Company Limited (HNSPF)
OTC
Closed
Oct 6, 2026
Day's Range
4.2552 wk Range
3.83Overview - HNSPF - Hansoh Pharmaceutical Group Company Limited
Key Statistics
Valuation
Enterprise Value
-1.10B
P/E (Trailing)
‪30.35‬
Price / Sales (TTM)
‪1.62‬
Price / Book
‪4.56‬
EV / EBITDA
‪-1.17‬
Profitability
Profit Margin
‪42.00%‬
Operating Margin
‪44.37%‬
Return on Assets
‪9.08%‬
Return on Equity
‪19.39%‬
Ownership
Shares Outstanding
6.05B
Float
1.23B
Held by Insiders
‪79.55%‬
Held by Institutions
‪12.73%‬
Price stats
Beta
‪0.56‬
50-Day Avg
‪4.17‬
200-Day Avg
‪4.54‬
Dividends
Payout Ratio
‪36.07%‬
Frequency
Semi-Annual
Shariah Compliance
Report Date: Feb 19, 2025
Screened by Zoya using the AAOIFI methodology.
Market Cap - HNSPF - Hansoh Pharmaceutical Group Company Limited
Peers - HNSPF - Hansoh Pharmaceutical Group Company Limited
Peer Comparison
Compared with companies in Drug Manufacturers - Specialty & Generic listed on OTC.
- HNSPFOTCHansoh Pharmaceutical Group Company Limited25.76BMarket Cap-5.88%52-week change30.36P/E (Trailing)‪42.00%‬Profit Margin
- MKGAFOTCMerck KGaA67.92BMarket Cap+9.27%52-week change25.32P/E (Trailing)‪11.21%‬Profit Margin
- MKKGYOTCMerck KGaA Sponsored ADR67.10BMarket Cap+8.97%52-week change24.90P/E (Trailing)‪11.21%‬Profit Margin
- GALDYOTCGalderma Group AG Unsponsored ADR45.20BMarket Cap+7.87%52-week change53.10P/E (Trailing)‪14.57%‬Profit Margin
- GDERFOTCGalderma Group AG44.15BMarket Cap+11.81%52-week change51.88P/E (Trailing)‪14.57%‬Profit Margin
- JHPCYOTCJiangsu Hengrui Pharmaceuticals Co. Ltd.43.14BMarket Cap-30.46%52-week change37.14P/E (Trailing)‪86.20%‬Profit Margin
- HLNCFOTCHaleon plc38.69BMarket Cap+1.79%52-week change18.58P/E (Trailing)‪14.55%‬Profit Margin
Profile Summary - HNSPF - Hansoh Pharmaceutical Group Company Limited
About
Hansoh Pharmaceutical Group Company Limited undertakes the manufacturing and selling of pharmaceutical drugs primarily across China. As a leader in the Chinese pharmaceutical industry, Hansoh specializes in the research, development, production, and commercialization of therapeutic products targeting various complex…
The information on this page is provided for general informational purposes only and is not investment advice.
Market data provided by Twelve Data. Shariah compliance data provided by Zoya. Charting by TradingView.
Last updated:
